Literature DB >> 7225083

Improved method for the identification of the fluoride-resistant plasmacholinesterase genotypes.

E K Zsigmond, K B Flynn, S P Kothary.   

Abstract

This investigation was prompted by the findings that (1) dibucaine-resistant homozygotes and heterozygotes for plasmacholinesterase also exhibit resistance to fluoride inhibition, (2) the differentiation of dibucaine-resistant from the fluoride-resistant genotypes is ambiguous with the method of Harris and Whittaker, (3) the plasmacholinesterase inhibition by Na fluoride (FN) is markedly influenced by the temperature. Therefore, we modified their method by increasing (1) the temperature of the reaction from 25C to 37C and (2) the concentration of Na fluoride from 5.0 x 10(-5) M to 2.5 x 10(-4) M. With this method, gentically normal individuals have a mean FN + or - SD equals 43.0 + or - 10.0 and atypical dibucaine-resistant heterozygotes 67.0 + or - 5.37. Since a linear correlation was observed between DN and FN by our new method, a fluoride number 2 SD lower than the predicted FN from the DN can distinctly identify the fluoride-resistant plasmacholinesterase genotype Ef.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7225083     DOI: 10.1007/bf00500119

Source DB:  PubMed          Journal:  Biochem Genet        ISSN: 0006-2928            Impact factor:   1.890


  8 in total

1.  THE PSEUDOCHOLINESTERASE VARIANTS: ESTERASE LEVELS AND INCREASED RESISTANCE TO FLUORIDE.

Authors:  M WHITTAKER
Journal:  Acta Genet Stat Med       Date:  1964

2.  The relation between plasma cholinesterase and prolonged apnea caused by succinylcholine.

Authors:  F F FOLDES; V M FOLDES; J C SMITH; E K ZSIGMOND
Journal:  Anesthesiology       Date:  1963 Mar-Apr       Impact factor: 7.892

3.  Differential inhibition of human serum cholinesterase with fluoride: recognition of two new phenotypes.

Authors:  H HARRIS; M WHITTAKER
Journal:  Nature       Date:  1961-07-29       Impact factor: 49.962

4.  Reactivation of neostigmine inhibited human plasma cholinesterase.

Authors:  F F FOLDES; E G ERDOS; E K ZSIGMOND; J A ZWARTZ
Journal:  J Pharmacol Exp Ther       Date:  1960-08       Impact factor: 4.030

5.  Correspondence: Fluoride numbers.

Authors:  E K Zsigmond
Journal:  Br J Anaesth       Date:  1973-10       Impact factor: 9.166

6.  Initial experiences with the Cholinesterase Research Unit.

Authors:  M Whittaker; M D Vickers
Journal:  Br J Anaesth       Date:  1970-11       Impact factor: 9.166

7.  A study of the pseudocholinesterase in 78 cases of apnoea following suxamethonium.

Authors:  J C Thompson; M Whittaker
Journal:  Acta Genet Stat Med       Date:  1966

8.  Floride inhibition in patients with atypical dibucaine-resistant plasmacholinesterase.

Authors:  S P Kothary; K B Flynn; E K Zsigmond
Journal:  Biochem Genet       Date:  1979-12       Impact factor: 1.890

  8 in total
  2 in total

1.  A new high activity plasma cholinesterase variant.

Authors:  A Krause; A B Lane; T Jenkins
Journal:  J Med Genet       Date:  1988-10       Impact factor: 6.318

2.  An improved method for butyrylcholinesterase phenotyping.

Authors:  G Picheth; C Fadel-Picheth; S L Primo-Parmo; E A Chautard-Freire-Maia; M M Vieira
Journal:  Biochem Genet       Date:  1994-04       Impact factor: 1.890

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.